The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis

Autor: Buket Öztürk Esen, Rikke Nørgaard Pedersen, Deirdre Cronin-Fenton, Lene Mellemkjær, Timothy L. Lash, Bent Ejlertsen, Peer Christiansen, Mette Nørgaard

Publikováno v: J Natl Cancer Inst
Pedersen, R N, Esen, B Ö, Mellemkjær, L, Christiansen, P, Ejlertsen, B, Lash, T L, Nørgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years after Primary Diagnosis ', Journal of the National Cancer Institute, vol. 114, no. 3, pp. 391–399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B O, Mellemkjaer, L, Christiansen, P, Ejlertsen, B, Lash, T L, Norgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis ', National Cancer Institute. Journal (Online), vol. 114, no. 3, pp. 391-399 . https://doi.org/10.1093/jnci/djab202

Background Extended, more effective breast cancer treatments have increased the prevalence of long-term survivors. We investigated the risk of late breast cancer recurrence (BCR), 10 years or more after primary diagnosis, and associations between pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b9bf6a76ac3d13fa2f55ffe0f0314ab
https://pubmed.ncbi.nlm.nih.gov/34747495

Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse

Autor: Saba Ferdous, Charles Swanton, Francesca Chemi, Chang Sik Kim, Selvaraju Veeriah, Ged Brady, Sakshi Gulati, Deborah J. Burt, Mariam Jamal-Hanjani, Fiona H Blackhall, Daniel Slane-Tan, Nicholas McGranahan, Jackie Pierce, Marek Dynowski, Crispin J. Miller, Barbara Mesquita, Dominic G. Rothwell, Cong Zhou, David Allan Moore, Simon P. Pearce, Fabio Gomes, Philip A.J. Crosbie, Jonathan Tugwood, Nicolai Juul Birkbak, R. Shah, Gareth A. Wilson, Christopher Abbosh, Sophia Ward, Maise Al Bakir, Allan Hackshaw, Crispin T. Hiley, Caroline Dive, Dhruva Biswas, Yvonne Summers

Publikováno v: Chemi, F, Rothwell, D G, McGranahan, N, Gulati, S, Abbosh, C, Pearce, S P, Zhou, C, Wilson, G A, Jamal-Hanjani, M, Birkbak, N, Pierce, J, Kim, C S, Ferdous, S, Burt, D J, Slane-Tan, D, Gomes, F, Moore, D, Shah, R, Al Bakir, M, Hiley, C, Veeriah, S, Summers, Y, Crosbie, P, Ward, S, Mesquita, B, Dynowski, M, Biswas, D, Tugwood, J, Blackhall, F, Miller, C, Hackshaw, A, Brady, G, Swanton, C, Dive, C & TRACERx Consortium 2019, ' Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse ', Nature Medicine, vol. 25, no. 10, pp. 1534-1539 . https://doi.org/10.1038/s41591-019-0593-1
TRACERx Consortium 2019, ' Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse ', Nature Medicine, vol. 25, no. 10, pp. 1534-1539 . https://doi.org/10.1038/s41591-019-0593-1

Approximately 50% of patients with early-stage non-small-cell lung cancer (NSCLC) who undergo surgery with curative intent will relapse within 5 years1,2. Detection of circulating tumor cells (CTCs) at the time of surgery may represent a tool to iden

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d6ddd0b6c3e7f59bde65bfbe961685
https://doi.org/10.1038/s41591-019-0593-1

Risk-based breast cancer follow-up stratified by age

Autor: Judith B. Timmer, Annemieke Witteveen, Ingrid M. H. Vliegen, Sabine Siesling, Maarten Joost IJzerman, Jan W. M. Otten

Publikováno v: Cancer Medicine, 7(10), 5291-5298. Wiley
Cancer medicine, 7(10):CAM41760, 5291-5298. Wiley
Cancer Medicine

Although personalization of cancer care is recommended, current follow-up after the curative treatment of breast cancer is consensus-based and not differentiated for base-line risk. Every patient receives annual follow-up for 5 years without taking i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50a460570da2fa9d4a9a07a8c7c44c5f
https://doi.org/10.1002/cam4.1760

Detection of recurrence in early stage endometrial cancer – the role of symptoms and routine follow-up

Autor: Maria Iachina, Malene Korsholm, Pernille Tine Jensen, Ole Mogensen, Dorte Gilså Hansen, Mette Moustgaard Jeppesen

Publikováno v: Jeppesen, M M, Mogensen, O, Hansen, D G, Iachina, M, Korsholm, M & Jensen, P T 2017, ' Detection of recurrence in early stage endometrial cancer : the role of symptoms and routine follow-up ', Acta Oncologica, vol. 56, no. 2, pp. 262-269 . https://doi.org/10.1080/0284186X.2016.1267396

Background: Considerable controversy remains as to the optimal organization of endometrial cancer follow-up. Aim: To evaluate the relationship between the way recurrence was detected and survival after treatment for endometrial cancer. Further, to id

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb7935ff1dbb618443f270fb4fbdea98
https://doi.org/10.1080/0284186x.2016.1267396

Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry

Autor: Gert De Hertogh, Elisabeth Macken, Raf Bisschops, Marc Ferrante, Hans Orlent, Hilde Willekens, Paul Christiaens, Joke Vliebergh, Fazia Mana, Pierre Henri Deprez, Danny De Looze

Publikováno v: Endoscopy, Vol. 51, no.4, p. 317-325 (2019)
Endoscopy: journal for clinical use, biopsy and technique

Background Radiofrequency ablation (RFA), combined with endoscopic resection, can be used as a primary treatment for low grade dysplasia, high grade dysplasia, and early esophageal adenocarcinoma (EAC) in Barrett’s esophagus (BE). The aim of the Be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acde560074a9e3e2b207211030f76de4
https://hdl.handle.net/2078.1/237274